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SUMMARY 
Objectives: To evaluate the clinical, nutritional and neurodevelopment status of 
HIV-infected children in a high HIV prevalence area. 
Methods: All HIV-infected children under 15 years of age attending an outpatient 
clinic of Mozambique between April and May 2010 were recruited. Clinical data 
were collected and physical examination was performed.  
Results: 140 children were recruited. The median age at HIV diagnosis was 2.1 
years. Fifty-one percent of the children were classified in WHO Clinical Stages 3 or 
4. Median age of antiretrovirals commencement was 3.9 years. Overall, 68% were 
undernourished, mainly stunted. Forty-four percent failed to pass the national 
psychomotor developmental test.  
Conclusions: The pathways for early HIV diagnosis and start of antiretrovirals in 
children should be improved in Mozambique. Malnutrition, especially stunting, and 
developmental delay were highly prevalent. Further research focused on early 
diagnosis of neurocognitive disorders and on the indications of antiretrovirals 
commencement based on chronic malnutrition is required.  
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INTRODUCTION 
HIV constitutes a major global health problem, especially in Sub-Saharan Africa.1 
Early diagnosis and treatment are essential in the management of HIV-infected 
children.2, 3  
Mozambique presents a high HIV prevalence/incidence and high mother to child 
transmission (HIV-MTCT) rates, 4,5,6 but there is little published data on paediatric 
HIV infection in Mozambique. 7, 8, 9, 10 The aim of the present study was to know the 
status of HIV-infected children in a semi-rural area in Mozambique in order to 
improve the health response to the needs of the population. 
 
METHODS 
Study area 
The study was carried out during April and May 2010 in Manhiça District, where the 
Manhiça District Hospital (MDH) and the Manhiça Health Research Centre (CISM) 
are located. The study area has been described in detail elsewhere.11 HIV 
prevalence in adults (18-47 years of age) was 37.5%6 and 1.4% in children ≤11 
years old.12 The HIV-MTCT rates in the first month of life and during infancy were 
9% and 27%, respectively.4 Estimates from the antenatal clinic of MDH showed an 
HIV prevalence of 23.6%.13,14 HIV counselling, testing and treatment to prevent 
HIV-MTCT with nevirapine are available and free of charge since 2003, and Highly 
Active Anti-Retroviral Therapy (HAART) since 2004.15 At the time of the study, 
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HAART was indicated for women in WHO disease stage 3 or 4 or CD4 <250 
counts/µl. For the rest of the mothers, HIV-MTCT prevention was based on Anti-
Retrovirals (ART) monotherapy from 28 weeks of gestation, plus combined ART 
during labour. New-borns received a single dose of nevirapine at birth and daily 
zidovudine during 4 weeks. A special clinic for HIV-exposed children established 
by the Ministry of Health, where HIV DNA-PCR testing was available, followed 
children monthly during the infancy. At the time of the study, the National 
Expanded Program on Immunization (EPI) included BCG vaccine (newborn 
period), oral polio, DTP, hepatitis B and Hib vaccines (2, 4 and 6 months) and 
measles vaccine (9 months). In the area 95% of the children were correctly 
vaccinated (Lanaspa et al., personal communication). 
Since 1996 CISM runs a demographic surveillance system that involves over 
87700 inhabitants, whereby all paediatric visits at the MDH are registered. All the 
information was collected on paper-based forms and stored in a relational 
database implemented in Microsoft Fox ProTM.11 Since 2003 there is a specific 
outpatient clinic which is the reference centre for all the HIV-infected children in the 
area and the only ART supplier. Around 1000 HIV-infected children were visited at 
least once in the clinic. HIV care followed the 2008 WHO guidelines, which 
recommended starting ART in all infants and based on WHO criteria for children >1 
year. 16 
Study design  
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The study was descriptive and cross-sectional with two components: a prospective 
assessment of children who attended the clinic during the study, and retrospective 
review of his/her clinical records. All children (<15 years) attending the HIV 
outpatient clinic during the study period whose caregivers provided informed 
consent were recruited.  
Physical examination and a standardized questionnaire were undertaken. 
Psychomotor development evaluation was performed in children <6 years of age 
using the test included in the Mozambique National Child Health Card17 (Table 1). 
Past medical history was obtained from paper case record review, direct interview 
of parent(s)/guardian, and from the clinical surveillance system. Clinical and 
immunological stages were defined following the WHO definitions.16 Data clerks 
double entered the information into OpenClinica, (Akaza Research LLC). 
The clinical protocol was approved by the Ethics Committee of the Liverpool 
School of Tropical Medicine, the Mozambican National Bioethics Committee and 
the Ethics Committee of the Hospital Clínic in Barcelona. All parents/guardians 
gave written informed consent.  
 
Statistical analysis 
Data were analysed using the Statistical Package for Social Sciences for Windows 
version 17 (SPSS Incorporated, Illinois). Mean Z scores for height-for-age (HAZ), 
weight-for-age (WAZ), weight-for-height (WHZ) and body mass index (BMI)-for-age 
were calculated using Stata version 9.0 (StataCorp LP) and CDC 2000 growth 
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references. These standards were chosen instead of the WHO growth references 
because the later only calculate WHZ scores up to 5 years and WAZ scores up to 
10 years. Underweight, stunting and wasting were defined by WAZ, HAZ, 
WHZ/BMI Z scores <2 standard deviations, respectively. To describe differences 
related with the clinical follow-up, children have been classified in two groups, less 
or more than 6 months of follow-up.  
Comparisons between groups for categorical variables were assessed using the 
chi-square test and for continuous variables using unpaired t-tests for normally 
distributed and Mann-Whitney U test for non-normally distributed. The Kruskal-
Wallis test was used for comparisons among 3 groups (categorical variables and 
non-normally distributed) and one-way analysis of variance (ANOVA) to compare 
continuous variables if normally distributed. Associations between categorical 
variables were explored using univariate logistic regression. A p-value of <0.05 
was considered significant.  
 
RESULTS 
Study population 
A total of 149 children were visited at the clinic during the study period. One 
hundred and forty children were recruited and 9 refused to participate because the 
study activities lengthened the duration of the visit. Twenty four children (17%) 
were enrolled at their first visit to the clinic. The rest (83%) had been followed-up in 
the clinic for a median of 15 months (0.6-64 months). 
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The general characteristics of the children are presented in Table 2. The median 
age of the children was of 3.8 years (3.6 months to 14.9 years). Most of the 
children (139/140) were considered to have been infected through vertical 
transmission and one by scarification rituals.  
Characteristics at the time of diagnosis 
At the time of diagnosis the median age was 2.1 years and only 18% of children 
were <1 year. Forty seven percent of the children were in clinical disease stage 3 
or 4. Compared to the rest, children diagnosed in the six months prior to the study 
start were younger (1.7 vs. 2.9 years; p=0.003), and had less advanced 
progressive clinical disease at diagnosis (p=0.046), but not less advanced 
immunological stages (p=0.066). 
Up to 74% of the children were malnourished. The proportions with underweight, 
stunting and wasting were 63%, 57% and 31%, respectively.  
Characteristics at the scheduled visit 
At the time of visit 83 children (59.3%) presented clinical symptoms. Of these, 51% 
presented cough <15 days, 27.8% skin lesions, 16.9% fever and 13.3% cough ≥15 
days. Ninety one percent had some abnormal finding on physical examination: 
55% respiratory tract infection, 51% skin lesions, 38% generalized 
lymphadenopathy, 33% hepatosplenomegaly and 23% parotitis. Fifty nine percent 
had previous recorded admissions at the MDH over the preceding 7 years. The 
median number of admissions was 1.5 (1-9) and the principal causes were 
pneumonia (24%), anaemia (19%), malaria (15%), diarrhoea (11%) and 
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undernutrition (11%). Overall, 22 (15.7%) children had been diagnosed with 
tuberculosis at some point (21 pulmonary tuberculosis and one lymph node 
disease). Clinical and immunological characteristics are presented in Table 3.  
Sixty eight percent of all children had at least one Z score growth indicator <-2 
(Table 4). Children <2 years of age were more wasted than older children (34% 
compared to 15% for 2-5 years, and 10% for >5 years; p=0.025). Children ≥2 years 
were more severely stunted than younger children (34% vs. 9%, p=0.025).  
Of the 95 evaluated children, 42 (44%) failed the psychomotor development test. 
The median age was 2.09 years and 3.14 years for delayed and non-delayed 
children, respectively (p=0.05). In univariate logistic regression analysis, illiterate 
caregivers were 2.6 times more likely to have a child with delayed psychomotor 
development compared to caregivers who could read and write (OR: 2.64; 95% CI: 
1.1-3.32). Other studied factors not showing significant results were: clinical and 
immunological stage at time of scheduled visit and at diagnosis, sex, ART, non-
maternal caregiver and the anthropometric Z scores. 
Antiretroviral treatment 
The characteristics of children based on their ART status are presented in Table 5. 
Of the study patients, 64 children (46%) were on ART. The median age of ART 
commencement was 3.9 years (5 months-13.7 years). Among children receiving 
ART, only 6% were <1 year of age at the beginning of the therapy. Seventy five 
percent of the children who had been on ART for <6 months had advanced to 
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severe immunosuppression, compared to 11% of those who were on treatment for 
≥6 months, and 56% for those ART naïve.  
The median time from diagnosis until ART commencement was 3.4 months (0.23-
49.03). Twenty percent (15/76) of ART naïve children had WHO clinical stage 4, 
and another 22% (17/76) were severely stunted at the day of the scheduled visit. 
 
DISCUSSION 
This study describes the clinical, nutritional and immunological characteristics, at 
the time of diagnosis or subsequent scheduled visits, of HIV-infected children 
attending an outpatient clinic in an area of very high HIV incidence.5 The results 
show that late diagnosis was very frequent. Therefore few children had been 
started on ART during infancy. This is one of the difficulties in the implementation 
of the WHO recommendations in low-income countries. This has been observed in 
similar sites. Reasons for late diagnosis could be the stigma of being visited in the 
especial out-patient clinic for HIV-exposed children, the delay in delivering the HIV-
DNA results and the lack of resources for transportation.18, 19 Furthermore, the long 
exposition through breast milk could be associated to more late vertical infections 
with no follow-up. Despite this, some progress had been observed in the diagnosis 
of the children followed-up <6 months showing the efforts done to accomplish the 
guidelines introduced in 2009. The latest WHO guidelines advocate starting ART 
for all children <5 years of age and included ART for children during all the time of 
breastfeeding.3 This new recommendation is more adapted to the real situation. It 
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will allow more children with late diagnosis to start ART treatment before reaching 
an advanced disease and will avoid late infections. Despite this earlier and rapid 
diagnosis, preferably by rapid test, is still necessary to improve these children’s 
prognosis.2, 3 It could be useful to test strategies that permit to diagnose children at 
any point of contact with the health system. 20 The integration of early diagnosis 
strategies into the EPI programme would avoid the stigma and be useful given that 
the majority of children do attend these scheduled visits. This strategy has been 
beneficial in similar settings.21 
 
Current WHO guidelines recommend starting ART in children presenting with 
“unexplained” severe malnutrition not responding to standard nutritional treatment. 
22 However undernutrition was highly prevalent among the study population. This 
was similar to the growth failure reported in other studies.23, 24, 25 Besides the HIV 
related growth failure, the chronic endemic malnutrition in this setting26 could act as 
the main driving force influencing the observed undernutrition. This situation could 
downplay the HIV as main cause of undernutrition and mislead the AIDS diagnosis 
based on anthropometric data. Specifically, stunting is not considered as a key 
clinical feature for ART commencement. In this study, 17/76 ART naïve children 
were severely stunted at the day of the scheduled visit. The indication and optimal 
timing of ART commencement based on undernutrition, especially in stunted 
children, is unclear and difficult to apply. Further research about the strategies to 
provide the most adequate nutritional support for HIV-infected children in 
developing settings and better clinical monitoring of stunted children are needed.27 
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In this study a high proportion of children failed the developmental screening test. 
These results match with the information from different Sub-Saharan settings.28,29 
In these studies, Western development tests or insufficiently sensitive 
measurement tools were used, emphasizing the need of using locally adapted 
developmental tests.30 The test used in this study is a screening tool administered 
at national level as part of the children’s routine health status evaluation. Even 
locally developed, the simplicity of the test could have underestimated 
neurocognitive impairment in these children. However, more than 44% of HIV-
infected children failed the test, which is more than the 5% of failures observed 
among HIV-uninfected children of Manhiça, highlighting the importance of this 
problem in the HIV population (Sevene et al., personal communication). 
Explanations for the huge difference between the groups could be the fact that in 
this study, the test was applied by an especially trained paediatrician, and that the 
data of HIV-uninfected children only included children of 9 months of age. Even if 
the difference would be smaller, the high proportion of developmental delay in the 
HIV-infected group urgently needs to be reduced. To identify the main risk factors 
associated with this developmental delay, in order to implement adequate 
interventions, as well as early HIV treatment are key elements to prevent this 
condition.31 In addition to HIV, other factors such as undernutrition, other infectious 
diseases, poverty, low maternal education, may contribute to the observed 
neurocognitive deficits. 32, 33,34 In this study, only illiterate caregivers were found to 
be related with delayed psychomotor development. It could be that the sample size 
was too small, or that HIV-infection itself could have a greater influence on 
neurological development than the other studied factors. 
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The main limitation of the study is that the recruited children might be a selected 
sample of HIV-infected children from the area of Manhiça, which has a relatively 
good access to health services. However, this would also indicate that the clinical 
situation of those not attending the health facilities is likely to be worse. Children on 
ART were seen more often in the outpatient clinic, especially in the first months 
after ART commencement. Therefore the proportion of children on ART for this 
sample (45%) was higher than that for the whole of children on follow-up in the 
programme (20%) (data not shown) Thus, these results cannot be generalized to 
the whole of children attending the outpatient clinic at MDH. Another limitation is 
the lack of a control group of HIV-uninfected children.  
In summary, the findings of this study show that the diagnosis of HIV-infection in 
children attending this health facility is often delayed and they present very 
frequently undernutrition, especially stunting, and developmental delay. Similar 
findings have been observed in other sites23, 29, 35 and it represents a failure of the 
health care system. This could interfere in the reduction of the mortality in children 
under 5 years old, considering that HIV infection is one of the main causes of 
mortality in children.36 There is an urgent need to further improve the pathways to 
facilitate an early diagnosis, ART start and nutritional counselling to African HIV-
infected children. Further research focused on early diagnosis of neurocognitive 
deficits and on the indications of ART commencement based on chronic 
malnutrition is required. 
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Table 1: Psychomotor test included in the Mozambique National Child 
Health card translated 
Signs Age 
(months) 
Follows the object with his/her eyes and turns the head to the 
sound 
Up 2 
Holds the head and smiles when somebody talk to him/her 3-5 
Sits alone without support 6-8 
Crawls and stands up with support 9-11 
Walks holding hands and says “ta-ta” 12-17 
Walks alone and uses from 6 to 20 words 18-23 
Runs and says his/her name 24-59 
Dresses him/herself and counts the five fingers of the hand From 60 
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Table 2: Characteristics of the study population 
General characteristics N=140 
Male [n (%)]  75 (53.6) 
Age, years [median (range)] 3.79 (0.28-14.96) 
Children <1yr of age [n (%)] 14 (10.0) 
First visit [n (%)] 24 (17.1) 
Follow-up, months [median (range)] n=113 14.97 (0.6-64) 
On CTX [n (%)] 105 (75.0) 
On ART [n (%)] 64 (45.7) 
Breastfeeding [n (%)] 136 (97.1) 
Breastfeeding duration, months [median (range)] 18 (1-32) 
>6 years attending school [n (%)]  45 (50.0) 
Both parents alive [n (%)] 106 (75.7) 
HIV+ mothers on follow-up [n (%)], (n=116) 101 (87.1) 
HIV+ mothers on ART [n (%)], (n=101) 48 (47.5) 
Nº of live births/mother [mean (SD)] n= 139 3.6 (+1.906) 
Mother as main caregiver [n (%)] 109 (77.9) 
Illiterate caregiver [n (%)] 59 (42.1) 
Nº of residents [mean (SD)] 6.41 (+3.135) 
Nº of residents under 15 [mean (SD)] 3.25 (+1.699) 
Running water in household [n (%)] 29 (20.7) 
Access to TV, radio, newspaper [n (%)] 59 (42.1) 
CTX: Cotrimoxazol; ART: Antiretroviral treatment; SD: Standard deviation 
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Table 3: Clinical and immunological characteristics at the schedule visit 
based on time of follow-up 
Characteristic All (N=140) F-U <6m (N=62) F-U > 6m (N=78) p 
Age, years  [median (range)] 3.79 (0.28-14.96) 1.87 (0.28-12.87) 5.66 (1.04-14.96) <0.001 
Clinical symptoms [n (%)] 83 (59.3) 36 (58.1) 47 (60.3) 0.464 
Abnormal finding at Clin Ex 128 (91.4) 57 (91.9) 71 (91.0) 1 
WHO Clinical stages [n (%)]    
 
1 32 (22.9) 23 (37.1) 9 (11.5) 
0.004 
2 36 (25.7) 15 (24.2) 21 (26.9) 
3 35 (25.0) 11 (17.7) 24 (30.8) 
4 37 (26.4) 13 (21) 24 (30.8) 
Immunological stage [n (%)] n=78 n=23 n=55  
1 35 (44.9) 1 (4.3) 34 (61.8) 
<0.001 
2 14 (17.9) 5 (21.7) 9 (16.4) 
3 8 (10.3) 4 (17.4) 4 (7.3) 
4 21 (26.9) 13 (56.5) 8 (14.6) 
Developmental delay [n (%)] 
(n=95) 42 (44.2) (n=52) 28 (53.8) (n=43) 14 (32.6) 0.038 
F-U <6m: Follow-up for less than 6 months; F-U > 6m: Follow-up for 6 or more months; Clin Ex: 
Clinical examination;  
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Table 4: Growth parameters at time of scheduled visit 
Growth parameters All (N=136) F-U <6m (N=59) F-U > 6m (N=77) p 
Overall malnutrition [n (%)] 93 (68.4) 43 (72.9) 50 (64.9) 0.357 
WAZ<-2 [n (%)]  (n=136) 64 (47.1) 36 (61.0) 28 (36.4) 0.006 
 WAZ <-2- > -3 22 (16.2) 10 (16.9) 12 (15.6) 1 
 WAZ <-3 42 (30.9) 26 (44.1) 16 (20.8) 0.005 
HAZ<-2 [n (%)]  (n=136) 78 (57.4) 35 (59.3) 43 (55.8) 0.729 
 HAZ <-2- > -3 40 (29.4) 22 (37.3) 18 (23.4) 0.090 
 HAZ <-3 38 (27.9) 13 (22.0) 25 (32.5) 0.247 
WHZ<-2 [n (%)]  (n=118) 22 (18.6) 17 (30.9) (n=55) 5 (7.9) (n=63) 0.002 
 WHZ <-2- > -3 10 (8.5) 6 (10.9) 4 (6.4) 0.511 
 WHZ <-3 12 (10.2) 11 (20) 1 (1.6) 0.001 
BMIZ<-2 [n (%)]  (n=104) 14 (13.5) 6 (20) (n=30) 8 (10.8) (n=74) 0.221 
 BMIZ <-2- > -3 9 (8.7) 3 (10) 6 (8.1) 0.715 
 BMIZ <-3 5 (4.8) 3 (10) 2 (2.7) 0.143 
WAZ (mean, SD) (n=136) -2.17 (+1.55) -2.62 (+1.68) -1.82 (+1.34) 0.004 
HAZ (mean, SD) (n=136) -2.19 (+1.26) -2.16 (+1.16) -2.21 (+1.33) 0.807 
WHZ (mean, SD) (n=118) -0.71 (+1.63) (n=55) -1.24 (+1.79) (n=63) -0.25 (+1.32) 0.001 
BMIZ (mean, SD) (n=104) -0.46 (+1.47) (n=30) -1.02 (+1.52) (n=74)-0.23 (+1.39) 0.019 
F-U <6m: Follow-up for less than 6 months; F-U > 6m: Follow-up for 6 or more months; WAZ: 
Weight-for-age z-score; HAZ: Height-for-age z-score; WHZ: Weight-for-height z-score; BMIZ: Body 
mass index z-score 
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Table 5: Clinical, immunological and nutritional characteristics based on 
ART status 
Characteristic Not on ART 
(n=76) 
On ART <6 
months (n=15) 
On ART >6 
months (n=49) 
p 
WHO Clinical stages [n (%)]     
1 26 (34.2) 2 (13.3) 4 (8.2) 0.010 
2 21 (27.6) 4 (26.7) 11 (22.5) 
3 14 (18.4) 6 (40.0) 15 (30.6) 
4 15 (19.7) 3 (20.0) 19 (38.8) 
Clinical symptoms [n (%)] 49 (64.5) 6 (40.0) 28 (57.1) 0.199 
Abnormal finding on Clin Ex 71 (93.4) 14 (93.3) 43 (87.8) 0.525 
Developmental delay [n (%)] 
(n=95) 
30 (50.9) (n= 59) 3 (30.0) (n=10) 9 (34.6) (n=26) 0.245 
Immunodeficiency [n (%)] n=34 n=8 n=36  
None or not significant 8 (23.5) 0 27 (75.0) <0.001 
Mild 7 (20.6) 2 (25.0) 5 (13.9) 
Advanced 6 (17.7) 1 (12.5) 1 (2.8) 
Severe 13 (38.2) 5 (62.5) 3 (8.3) 
CD4% [median (range)]<5y 
(n=33) 
20.5 (11-48) 
(n=20) 
19.3 (14.8-28) 
(n=3) 
32 (17-45.6) 
(n=13) 
0.007 
CD4/mm3 [median (range)] >5y 
(n=40) 
400.5 (163-1205) 
(n=14) 
338 (159-591)    
(n= 5) 
716 (76-2287) 
(n=23) 
0.001 
Overall malnutrition [n (%)] 48 (65.8) (n=73) 11 (73.4) (n=15) 34 (70.8) (n=48) 0.766 
WAZ<-2 [n (%)] 38 (52.1) 7 (46.7) 19 (39.6) 0.407 
HAZ<-2 [n (%)] 40 (54.8) 10 (66.7) 28 (58.3) 0.690 
WHZ<-2 [n (%)] 13 (19.7) (n=66) 4 (30.8) (n=13) 5 (12.8) (n=39) 0.339 
BMIZ<-2 [n (%)] 5 (10.6) (n=47) 1 (9.1) (n=11) 8 (17.4) (n=46) 0.577 
ART: Antiretroviral treatment; WAZ: Weight-for-age z-score; HAZ: Height-for-age z-score; WHZ: 
Weight-for-height z-score; BMIZ: Body mass index z-score; Clin Ex: Clinical examination 
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